Intra-Cellular Therapies, Inc. vs Aardvark Therapeutics, Inc., risk disclosures compared

4topics both disclose

6only Intra-Cellular Therapies, Inc.

2only Aardvark Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Intra-Cellular Therapies, Inc.	Aardvark Therapeutics, Inc.
Business Continuity	1	7
Ransomware	3	4
Cross Border Data Transfer	1	3
Data Residency	1	3

Only Intra-Cellular Therapies, Inc.

Topic	Filings
Internal Control	6
Regulatory Investigation	4
Whistleblower Program	3
Restatement	2
Third Party Risk Management	2
Material Weakness	1

Only Aardvark Therapeutics, Inc.

Topic	Filings
Audit Committee Oversight	2
ESG Reporting	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Intra-Cellular Therapies, Inc. · Aardvark Therapeutics, Inc. · All companies